​

Connect Biopharma (CNTB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Connect Biopharma Revenue Highlights

Latest Revenue (Y)

$26.03M

Latest Revenue (Q)

$1.91M

Main Segment (Y)

License

Connect Biopharma Revenue by Period

Connect Biopharma Revenue by Year

DateRevenueChange
2024-12-31$26.03M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Connect Biopharma generated $26.03M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Connect Biopharma Revenue by Quarter

DateRevenueChange
2024-12-31$1.91M-92.07%
2024-06-30$24.12M100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2021-12-31-100.00%
2021-06-30-100.00%
2020-12-31-100.00%
2020-06-30-100.00%
2019-12-31-100.00%
2019-06-30--

Connect Biopharma generated $1.91M in revenue during Q4 2024, up -92.07% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Connect Biopharma Revenue Breakdown

Connect Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
License$24.40M

Connect Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 24: License (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25
License$110.00M

Connect Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: License (100.00%).

Connect Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MGNXMacroGenics$149.96M$13.19M
CNTBConnect Biopharma$26.03M$1.91M
WHWKWhitehawk Therapeutics$25.98M$7.24M
SRZNSurrozen$10.65M$983.00K
SPRBSpruce Biosciences$4.91M-
ATYRaTyr Pharma$353.00K-
GUTSFractyl Health$120.00K-
ANEBAnebulo Pharmaceuticals--
QNCXQuince Therapeutics--
KLRSKalaris Therapeutics--
BMEABiomea Fusion--

CNTB Revenue FAQ

What is Connect Biopharma’s yearly revenue?

Connect Biopharma's yearly revenue for 2024 was $26.03M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. CNTB's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Connect Biopharma’s quarterly revenue?

Connect Biopharma's quarterly revenue for Q4 2024 was $1.91M, a -92.07% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q2 2024 was $24.12M, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). CNTB's quarterly revenue for Q4 2023 was $0, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Connect Biopharma’s revenue growth rate?

Connect Biopharma's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Connect Biopharma’s revenue streams?

Connect Biopharma's revenue streams in c 24 are License

What is Connect Biopharma’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Connect Biopharma was License. This segment made a revenue of $24.4M, representing 100.00% of the company's total revenue.